Search

Sanjay Lakhotia Phones & Addresses

  • 104 Via Floreado, Orinda, CA 94563 (925) 258-9780
  • Rockville, MD
  • Silver Spring, MD
  • 120 Roble Rd, Walnut Creek, CA 94597
  • Germantown, MD
  • San Ramon, CA
  • San Francisco, CA
  • Danville, CA
  • 104 Via Floreado, Orinda, CA 94563 (925) 367-7430

Work

Company: Pathway therapeutics Oct 2010 Position: Vice president, corporate development

Education

Degree: MBA School / High School: University of North Carolina at Chapel Hill - Kenan-Flagler Business School 1998 to 2000 Specialities: Business

Skills

Biotechnology • Corporate Development • Biopharmaceuticals • Life Sciences • Pharmaceutical Industry • Drug Development • Technology Transfer • Drug Discovery • Clinical Development • Fda • Lifesciences • Business Development • Commercialization • Clinical Trials

Languages

English

Industries

Biotechnology

Resumes

Resumes

Sanjay Lakhotia Photo 1

Chief Business Officer

View page
Location:
104 Via Floreado, Orinda, CA 94563
Industry:
Biotechnology
Work:
Pathway Therapeutics since Oct 2010
Vice President, Corporate Development

Portola Pharmaceuticals Jan 2006 - Sep 2010
Sr. Director, Corporate Development

Onyx Pharmaceuticals Apr 2004 - Jan 2006
Director, Corporate Development

MedImmune Sep 1999 - Apr 2004
Associate Director, Corporate Development

Wyeth, Lederle-Praxis Biologicals 1995 - 1999
Process Development Enginer
Education:
University of North Carolina at Chapel Hill - Kenan-Flagler Business School 1998 - 2000
MBA, Business
Northwestern University 1986 - 1992
Ph.D., Biochemical Engineering
University of California, Berkeley 1982 - 1986
BS, Chemical Engineering
Skills:
Biotechnology
Corporate Development
Biopharmaceuticals
Life Sciences
Pharmaceutical Industry
Drug Development
Technology Transfer
Drug Discovery
Clinical Development
Fda
Lifesciences
Business Development
Commercialization
Clinical Trials
Languages:
English

Publications

Us Patents

Extraction Of Integral Membrane Proteins

View page
US Patent:
7553634, Jun 30, 2009
Filed:
Jun 20, 2000
Appl. No.:
10/019163
Inventors:
Sanjay Lakhotia - Danville CA, US
Michael R. Biehl - Sanford NC, US
Assignee:
Wyeth Holdings Corporation - Madison NJ
International Classification:
C12P 1/00
A61K 39/00
A61K 39/21
US Classification:
435 41, 4241841, 4242081
Abstract:
A process is described for extracting gram-negative integral membrane proteins from bacteria or bacterial host cells containing a recombinant vector by differential detergent tangential flow diafiltration. This process has several advantages over alternate processes. First, it combines the clarification and extraction processes into one unit operation. The product is extracted from the cells and it is separated from cell debris with only one continuous diafiltration process. Second, the membrane proteins are extracted in a semi-purified state, which simplifies the downstream processing steps. Third, this process is very scalable because the only requirement is that the surface area of the membranes be increased proportionally with the amount of cells.
Sanjay J Lakhotia from Orinda, CA, age ~60 Get Report